Aditya K Gupta

Summary

Publications

  1. ncbi Sanitization of contaminated footwear from onychomycosis patients using ozone gas: a novel adjunct therapy for treating onychomycosis and tinea pedis?
    Aditya K Gupta
    Department of Medicine, University of Torondo, Torondo, ON, Canada
    J Cutan Med Surg 17:243-9. 2013
  2. ncbi Recurrences of dermatophyte toenail onychomycosis during long-term follow-up after successful treatments with mono- and combined therapy of terbinafine and itraconazole
    Aditya K Gupta
    Department of Medicine, University of Toronto, Toronto, ON, Canada
    J Cutan Med Surg 17:201-6. 2013
  3. doi Comparison of visual assessments versus planimetry assessments in a large-scale clinical trial of onychomycosis
    Aditya K Gupta
    Department of Medicine, Division of Dermatology, The University of Toronto, Toronto, Canada
    J Dermatolog Treat 25:256-9. 2014
  4. doi Systemic antifungals to treat onychomycosis in children: a systematic review
    Aditya K Gupta
    Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Canada Clinical Research, Mediprobe Research Inc, London, Ontario, Canada
    Pediatr Dermatol 30:294-302. 2013
  5. ncbi Onychomycosis therapy: past, present, future
    Aditya K Gupta
    Division of Dermatology, Department of Medicine, Sunnybrook Health Sciences Center, University of Toronto, Toronto, Canada
    J Drugs Dermatol 9:1109-13. 2010
  6. ncbi Do genetic mutations and genotypes contribute to onychomycosis?
    Aditya K Gupta
    Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ont, Canada
    Dermatology 228:207-10. 2014
  7. doi New therapeutic options for onychomycosis
    Aditya K Gupta
    Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada
    Expert Opin Pharmacother 13:1131-42. 2012
  8. ncbi Newly approved laser systems for onychomycosis
    Aditya K Gupta
    Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Canada
    J Am Podiatr Med Assoc 102:428-30. 2012
  9. doi Evidence-based optimal fluconazole dosing regimen for onychomycosis treatment
    Aditya K Gupta
    Department of Medicine, Division of Dermatology, University of Toronto, Toronto, Canada
    J Dermatolog Treat 24:75-80. 2013
  10. ncbi Efinaconazole: a new topical treatment for onychomycosis
    Aditya K Gupta
    Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada Mediprobe Research Inc, London, ON, Canada
    Skin Therapy Lett 19:1-4. 2014

Collaborators

Detail Information

Publications19

  1. ncbi Sanitization of contaminated footwear from onychomycosis patients using ozone gas: a novel adjunct therapy for treating onychomycosis and tinea pedis?
    Aditya K Gupta
    Department of Medicine, University of Torondo, Torondo, ON, Canada
    J Cutan Med Surg 17:243-9. 2013
    ..Ozone gas possesses antimicrobial properties against bacteria, viruses, and yeasts. Previously, we demonstrated the efficacy of ozone in killing ATCC strains of the dermatophyte fungi Trichophyton rubrum and Trichophyton mentagrophytes...
  2. ncbi Recurrences of dermatophyte toenail onychomycosis during long-term follow-up after successful treatments with mono- and combined therapy of terbinafine and itraconazole
    Aditya K Gupta
    Department of Medicine, University of Toronto, Toronto, ON, Canada
    J Cutan Med Surg 17:201-6. 2013
    ..The influence of dosing regimens on the recurrence rates of onychomycosis has not been investigated...
  3. doi Comparison of visual assessments versus planimetry assessments in a large-scale clinical trial of onychomycosis
    Aditya K Gupta
    Department of Medicine, Division of Dermatology, The University of Toronto, Toronto, Canada
    J Dermatolog Treat 25:256-9. 2014
    ..However, no published comparison of visual assessment with planimetry is currently available on onychomycosis to support this recommendation...
  4. doi Systemic antifungals to treat onychomycosis in children: a systematic review
    Aditya K Gupta
    Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Canada Clinical Research, Mediprobe Research Inc, London, Ontario, Canada
    Pediatr Dermatol 30:294-302. 2013
    ..In conclusion, based on the little information available on onychomycosis in children, systemic antifungal therapies in children are safe and cure rates are similar to the rates achieved in adults...
  5. ncbi Onychomycosis therapy: past, present, future
    Aditya K Gupta
    Division of Dermatology, Department of Medicine, Sunnybrook Health Sciences Center, University of Toronto, Toronto, Canada
    J Drugs Dermatol 9:1109-13. 2010
    ..Research in these fields is preliminary, and the impact these methods may have on the future of onychomycosis remains to be seen...
  6. ncbi Do genetic mutations and genotypes contribute to onychomycosis?
    Aditya K Gupta
    Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ont, Canada
    Dermatology 228:207-10. 2014
    ..Conclusions: There are documented mutations and genotypes that contribute to familial and individual susceptibility to onychomycosis. © 2014 S. Karger AG, Basel. ..
  7. doi New therapeutic options for onychomycosis
    Aditya K Gupta
    Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada
    Expert Opin Pharmacother 13:1131-42. 2012
    ..New therapeutic options are needed to broaden the spectrum of treatment options and improve the efficacy of treatment...
  8. ncbi Newly approved laser systems for onychomycosis
    Aditya K Gupta
    Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Canada
    J Am Podiatr Med Assoc 102:428-30. 2012
    ....
  9. doi Evidence-based optimal fluconazole dosing regimen for onychomycosis treatment
    Aditya K Gupta
    Department of Medicine, Division of Dermatology, University of Toronto, Toronto, Canada
    J Dermatolog Treat 24:75-80. 2013
    ..By restricting the data to dermatophyte onychomycosis, we aimed to identify an optimal fluconazole dosing regimen...
  10. ncbi Efinaconazole: a new topical treatment for onychomycosis
    Aditya K Gupta
    Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada Mediprobe Research Inc, London, ON, Canada
    Skin Therapy Lett 19:1-4. 2014
    ....
  11. ncbi The use of low-level light therapy in the treatment of androgenetic alopecia and female pattern hair loss
    Aditya K Gupta
    Department of Medicine, University of Toronto, Toronto, Canada
    J Dermatolog Treat 25:162-3. 2014
    ....
  12. ncbi Efinaconazole (Jublia) for the treatment of onychomycosis
    Aditya K Gupta
    Mediprobe Research Inc, 645 Windermere Rd, London, ON, Canada
    Expert Rev Anti Infect Ther 12:743-52. 2014
    ..Efinaconazole 10% nail solution is a safe and effective new topical therapy for onychomycosis, which will fill a pressing need for more effective topical therapy in this disease. ..
  13. ncbi The efficacy and safety of 5α-reductase inhibitors in androgenetic alopecia: a network meta-analysis and benefit-risk assessment of finasteride and dutasteride
    Aditya K Gupta
    Department of Medicine, Division of Dermatology, University of Toronto, Toronto, Canada
    J Dermatolog Treat 25:156-61. 2014
    ....
  14. ncbi Tavaborole (AN-2690) for the treatment of onychomycosis of the toenail in adults
    Aditya K Gupta
    Department of Medicine, University of Toronto, Toronto, Ontario, Canada
    Expert Rev Anti Infect Ther 12:735-42. 2014
    ..Tavaborole 5.0% nail solution has shown a favourable safety and efficacy profile in Phase II/III clinical trials and is currently under review for licensing in the US by the US Food and Drug Administration. ..
  15. ncbi Ingenol mebutate: a promising treatment for actinic keratoses and nonmelanoma skin cancers
    Aditya K Gupta
    Department of Medicine, University of Toronto, Toronto, ON, Canada
    J Cutan Med Surg 17:173-9. 2013
    ..A new treatment for actinic keratoses, ingenol mebutate, was recently approved by the US Food and Drug Administration...
  16. doi Sleep-wake disorders and dermatology
    Madhulika A Gupta
    Department of Department of Psychiatry, Schulich School of Medicine and Dentistry, University of Western Ontario, 585 Springbank Dr, Suite 101, London, ON, N6J 1H3, Canada
    Clin Dermatol 31:118-26. 2013
    ..Patient and parental reports of nocturnal itch and scratching in AD typically do not correlate with objective measures of scratching...
  17. doi A randomized study comparing the combination of nbUVB and etanercept to etanercept monotherapy in patients with psoriasis who do not exhibit an excellent response after 12 weeks of etanercept
    Charles W Lynde
    Lynderm Research, Markham, ON, Canada
    J Dermatolog Treat 23:261-7. 2012
    ..There is a lack of data on the combination of phototherapy with etanercept in patients who have not shown an excellent response to etanercept monotherapy...
  18. ncbi Psoriatic nail disease: quality of life and treatment
    Aditya K Gupta
    Division of Dermatology, Department of Medicine, Sunnybrook Health Sciences Centre and University of Toronto, Toronto, ON
    J Cutan Med Surg 13:S102-6. 2009
    ..Large-scale, long-term trials using standardized outcome measures are needed to further evaluate biologic therapies for the treatment of nail psoriasis...
  19. doi Update in antifungal therapy of dermatophytosis
    Aditya K Gupta
    Division of Dermatology, Department of Medicine, Sunnybrook Health Sciences Center, Toronto, ON, Canada
    Mycopathologia 166:353-67. 2008
    ..Relapse of infection remains a problem, particularly with tinea pedis/unguium. Appropriate follow-up duration and education of patients on proper foot hygiene are also important components in providing effective therapy...